Garcia-Donas J, Redondo A, Santaballa A, Garrigos L, et al. Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016-01). Gynecol Oncol 2024;191:233-239.
PMID: 39454227